HK1138215A1 - Glucan preparations - Google Patents

Glucan preparations

Info

Publication number
HK1138215A1
HK1138215A1 HK10103440.8A HK10103440A HK1138215A1 HK 1138215 A1 HK1138215 A1 HK 1138215A1 HK 10103440 A HK10103440 A HK 10103440A HK 1138215 A1 HK1138215 A1 HK 1138215A1
Authority
HK
Hong Kong
Prior art keywords
glucan preparations
glucan
preparations
Prior art date
Application number
HK10103440.8A
Other languages
English (en)
Chinese (zh)
Inventor
Andrew MAGEE
James Rolke
Ren-Der Yang
Original Assignee
Biopolymer Engineering Inc Dba Biothera Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biopolymer Engineering Inc Dba Biothera Inc filed Critical Biopolymer Engineering Inc Dba Biothera Inc
Publication of HK1138215A1 publication Critical patent/HK1138215A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
HK10103440.8A 2006-06-15 2010-04-07 Glucan preparations HK1138215A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81397106P 2006-06-15 2006-06-15
PCT/US2007/014055 WO2007146416A2 (en) 2006-06-15 2007-06-15 Glucan preparations

Publications (1)

Publication Number Publication Date
HK1138215A1 true HK1138215A1 (en) 2010-08-20

Family

ID=38832560

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10103440.8A HK1138215A1 (en) 2006-06-15 2010-04-07 Glucan preparations

Country Status (12)

Country Link
US (3) US9610303B2 (es)
EP (1) EP2032180B1 (es)
JP (3) JP2009540106A (es)
CN (2) CN101553261B (es)
BR (1) BRPI0713734A2 (es)
CA (1) CA2655414C (es)
ES (1) ES2628021T3 (es)
HK (1) HK1138215A1 (es)
IL (2) IL195937A (es)
MX (1) MX2008016039A (es)
RU (1) RU2490279C2 (es)
WO (2) WO2007146416A2 (es)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9610303B2 (en) 2006-06-15 2017-04-04 Biothera, Inc. Glucan preparations
US10111901B2 (en) 2014-07-10 2018-10-30 Biothera, Inc. Beta-glucan in combination with anti-cancer agents affecting the tumor microenvironment
US10111900B2 (en) 2014-11-06 2018-10-30 Biothera, Inc. β-glucan methods and compositions that affect the tumor microenvironment
US11815435B2 (en) 2017-02-24 2023-11-14 Hibercell, Inc. Beta glucan immunopharmacodynamics

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20014256D0 (no) 2001-09-03 2001-09-03 Bjoern Kristiansen Fremstilling av immunstimulerende forbindelse
US7514085B2 (en) 2004-07-16 2009-04-07 Medimush A/S Immune modulating compounds from fungi
WO2006133708A1 (en) * 2005-06-15 2006-12-21 Medimush A/S Bioactive agents produced by submerged cultivation of a basidiomycete cell
EP1896600A2 (en) 2005-06-15 2008-03-12 Medimush A/S Anti-cancer combination treatment and kit-of-part
US20080167268A1 (en) * 2006-09-01 2008-07-10 Jun Yan Particulate beta-glucan compositions for regulating dendritic cells
WO2008027581A1 (en) * 2006-09-01 2008-03-06 University Of Louisville Mcrp antagonists and their uses
CN101407559B (zh) * 2008-11-25 2011-01-26 天津科技大学 一种快速制备酵母β-1,3-葡聚糖的方法
FI20080665A0 (fi) * 2008-12-18 2008-12-18 Glykos Finland Oy Luonnollisen tyyppiset sakkaridikoostumukset
JP5172930B2 (ja) * 2009-10-20 2013-03-27 国立大学法人佐賀大学 高粘性培養液の粘性低下方法
WO2012154818A1 (en) 2011-05-09 2012-11-15 Biothera, Inc. B-glucan compounds, compositions, and methods
WO2012167061A1 (en) 2011-06-03 2012-12-06 Biothera, Inc. OPSONIZED β-GLUCAN PREPARATIONS AND METHODS
WO2013126669A1 (en) 2012-02-22 2013-08-29 Algal Scientific Corporation Animal feed compositions and methods of using the same
EP2854530B1 (en) 2012-04-30 2018-01-03 Biothera, Inc. Compositions for beta-glucan immunotherapy
CN106170698A (zh) 2013-12-05 2016-11-30 生物治疗公司 β‑葡聚糖测定方法
LT6145B (lt) 2014-04-14 2015-04-27 Uab "Biocentras" TERAPINĖ ß-GLIUKANŲ KOMPOZICIJA, MODULIUOJANTI ŽMOGAUS IMUNINĘ SISTEMĄ IR INICIJUOJANTI VĖŽINIŲ LĄSTELIŲ ARDYMĄ
TWI674070B (zh) 2014-11-19 2019-10-11 日商泰寶美客股份有限公司 酵母細胞之風味改善方法及食品品質改良劑
JP2016208909A (ja) * 2015-05-08 2016-12-15 株式会社カネカ 脂溶性生理活性物質の製造方法
JP6935877B2 (ja) * 2017-01-27 2021-09-15 日本製紙株式会社 免疫調整剤
JP6530846B1 (ja) * 2018-10-09 2019-06-12 アサヒグループホールディングス株式会社 免疫賦活剤及び感染予防方法
US11140912B1 (en) 2020-12-22 2021-10-12 Agvault, Llc Process for manufacturing yeast strains having increased mannan oligosaccharides and improved amino acid profiles
WO2023107712A1 (en) 2021-12-10 2023-06-15 Hibercell, Inc. SOLUBLE β-GLUCANS FOR INDUCING TRAINED IMMUNITY
CN115028755B (zh) * 2022-07-01 2023-08-11 福建省农业科学院食用菌研究所 一种高分子量绣球菌β-葡聚糖的制备方法

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810646A (en) 1984-11-28 1989-03-07 Massachusetts Institute Of Technology Glucan compositions and process for preparation thereof
US5082936A (en) 1984-11-28 1992-01-21 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
US5028703A (en) 1988-03-11 1991-07-02 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
US5250436A (en) * 1984-11-28 1993-10-05 Massachusetts Institute Of Technology Glucan compositions and process for preparation thereof
US4962094A (en) * 1988-10-28 1990-10-09 Alpha Beta Technology, Inc. Glucan dietary additives
US5032401A (en) * 1989-06-15 1991-07-16 Alpha Beta Technology Glucan drug delivery system and adjuvant
US5811542A (en) 1989-09-08 1998-09-22 Alpha-Beta Technology, Inc. Method for producing soluble glucans
US5488040A (en) * 1989-09-08 1996-01-30 Alpha-Beta Technology, Inc. Use of neutral soluble glucan preparations to stimulate platelet production
CA2066172A1 (en) * 1989-09-08 1991-03-09 Alpha Beta Technology, Inc. Method for producing soluble glucans
WO1991003248A2 (en) 1989-09-08 1991-03-21 Alpha Beta Technology, Inc. Method for immune system activation
US5622939A (en) 1992-08-21 1997-04-22 Alpha-Beta Technology, Inc. Glucan preparation
US6143731A (en) * 1989-10-20 2000-11-07 The Collaborative Group, Ltd. Glucan dietary additives
US6020324A (en) * 1989-10-20 2000-02-01 The Collaborative Group, Ltd. Glucan dietary additives
US5223491A (en) * 1989-11-09 1993-06-29 Donzis Byron A Method for revitalizing skin by applying topically water insoluble glucan
JP2547220Y2 (ja) 1990-07-19 1997-09-10 株式会社ユニシアジェックス アクチュエータ
US5519009A (en) * 1993-10-01 1996-05-21 Donzis; Byron A. Solubilized yeast glucan
US5622940A (en) * 1994-07-14 1997-04-22 Alpha-Beta Technology Inhibition of infection-stimulated oral tissue destruction by β(1,3)-glucan
US5576015A (en) * 1995-03-02 1996-11-19 Donzis; Byron A. Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses
AUPN166195A0 (en) 1995-03-13 1995-04-06 Norvet Research Pty Limited Process for glucan extraction
US6214337B1 (en) 1995-04-18 2001-04-10 Biotec Asa Animal feeds comprising yeast glucan
US6117850A (en) 1995-08-28 2000-09-12 The Collaborative Group, Ltd. Mobilization of peripheral blood precursor cells by β(1,3)-glucan
US6084092A (en) * 1997-01-31 2000-07-04 The Collaborative Group, Ltd. β(1-3)-glucan diagnostic assays
US6090938A (en) * 1996-05-01 2000-07-18 Collaborative Group, Ltd. Activation of signal transduction by underivatized, aqueous soluble . .beta(1-3)-Glucan
US6110692A (en) 1996-05-01 2000-08-29 The Collaborative Group, Ltd. Receptor for underivatized aqueous soluble β(1-3)-glucan
US6413715B2 (en) * 1997-01-31 2002-07-02 The Collaborative Group β(1-3)-glucan diagnostic assays
US6046323A (en) * 1997-07-29 2000-04-04 The Collaborative Group, Ltd. Conformations of PPG-glucan
US6369216B1 (en) 1998-09-25 2002-04-09 Biopolymer Engineering Pharmaceutical, Inc. Very high molecular weight β-glucans
AU6261999A (en) 1998-09-25 2000-04-17 Collaborative Group, Ltd., The Very high molecular weight beta-glucans
EP1124441B1 (en) * 1998-10-26 2007-09-05 Oatly AB Method for the isolation of a beta-glucan composition from oats and products made therefrom
US6143883A (en) * 1998-12-31 2000-11-07 Marlyn Nutraceuticals, Inc. Water-soluble low molecular weight beta-glucans for modulating immunological responses in mammalian system
JP2001342257A (ja) 2000-06-01 2001-12-11 Fuji Photo Film Co Ltd セルロース系ポリマーの製造方法
JP2002105101A (ja) 2000-10-03 2002-04-10 Ajinomoto Co Inc 水溶性高分子の製造法
US7786094B2 (en) 2001-10-09 2010-08-31 Biopolymer Engineering, Inc. Use of beta-glucans against biological warfare weapons and pathogens including anthrax
WO2004014320A2 (en) 2002-08-13 2004-02-19 Biopolymer Engineering, Inc. Methods of using beta glucan as a radioprotective agent
US20070042930A1 (en) 2002-08-13 2007-02-22 Ross Gordon D Effect of beta-glucan on stem cell recruitment and tissue repair
US20060165700A1 (en) 2002-09-04 2006-07-27 Ostroff Gary R Cancer therapy using whole glucan particles and antibodies
CN1939335A (zh) 2002-09-04 2007-04-04 路易斯维尔大学研究基金会 使用β葡聚糖和抗体治疗癌性的方法
CN1330671C (zh) 2002-10-08 2007-08-08 株式会社利根 含脱乙酰壳多糖的多糖、其制备方法和用途
WO2005078114A1 (ja) * 2004-02-13 2005-08-25 Alpron Co., Ltd. 酵母由来グルカンの製造方法
WO2006085895A2 (en) 2004-05-10 2006-08-17 Biopolymer Engineering, Inc. Whole glucan particles in combination with antibiotics, vaccines and viral monoclonal antibodies
GB0411880D0 (en) 2004-05-27 2004-06-30 Imagination Tech Ltd Method and apparatus for efficient evaluation of "table-based" mathematical functions
FI20040804A (fi) 2004-06-11 2005-12-12 Glubikan Ab Oy Menetelmä viljan ainesosan erottamiseksi
US20050020490A1 (en) * 2004-10-18 2005-01-27 Progressive Bioactives Incorporated A Method of Producing an Economical and Ecologically Sound Natural Immunobiotic Extract for Use as a Health Management Instrument and a Replacement for Growth Promotion Antibiotics in Livestock and Companion Animals.
WO2006119395A2 (en) 2005-05-03 2006-11-09 Biopolymer Engineering, Inc. Combination of a beta-glucan and an egf receptor antagonist for the treatment of cancer and infection
WO2007053608A2 (en) 2005-11-01 2007-05-10 Andries Hanzen Films and capsules made from modified carboxymethycellulose materials and methods of making same
US20090047288A1 (en) 2006-06-15 2009-02-19 Jun Yan Glucan compositions and methods of enhancing CR3 dependent neutrophil-mediated cytotoxicity
US9610303B2 (en) 2006-06-15 2017-04-04 Biothera, Inc. Glucan preparations
US20080167268A1 (en) 2006-09-01 2008-07-10 Jun Yan Particulate beta-glucan compositions for regulating dendritic cells
WO2008027581A1 (en) 2006-09-01 2008-03-06 University Of Louisville Mcrp antagonists and their uses
EP2146744A4 (en) 2007-04-24 2012-07-25 Univ Louisville Res Found THERAPEUTIC BETA-GLUCAN COMPOSITIONS
US7981447B2 (en) 2007-05-08 2011-07-19 Biothera, Inc. Particulate-soluble glucan preparation
JP5322119B2 (ja) 2007-10-08 2013-10-23 ビーエーエスエフ ソシエタス・ヨーロピア 反応器内部構造としての触媒特性を有する成形体の使用
JP5503952B2 (ja) 2009-12-09 2014-05-28 富士フイルム株式会社 印刷装置及び印刷制御方法

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9610303B2 (en) 2006-06-15 2017-04-04 Biothera, Inc. Glucan preparations
US10272101B2 (en) 2006-06-15 2019-04-30 Biothera Inc. Glucan preparations
US10111901B2 (en) 2014-07-10 2018-10-30 Biothera, Inc. Beta-glucan in combination with anti-cancer agents affecting the tumor microenvironment
US10111900B2 (en) 2014-11-06 2018-10-30 Biothera, Inc. β-glucan methods and compositions that affect the tumor microenvironment
US11815435B2 (en) 2017-02-24 2023-11-14 Hibercell, Inc. Beta glucan immunopharmacodynamics

Also Published As

Publication number Publication date
CA2655414A1 (en) 2007-12-21
WO2007146416A3 (en) 2008-03-13
EP2032180A4 (en) 2013-05-22
EP2032180A2 (en) 2009-03-11
US10272101B2 (en) 2019-04-30
JP6196280B2 (ja) 2017-09-13
WO2007146440A3 (en) 2008-02-07
ES2628021T3 (es) 2017-08-01
WO2007146440B1 (en) 2008-03-20
JP5851472B2 (ja) 2016-02-03
WO2007146416A2 (en) 2007-12-21
IL236842A (en) 2017-04-30
CN103833867B (zh) 2017-07-04
CN101553261A (zh) 2009-10-07
AU2007258191A1 (en) 2007-12-21
JP2014025079A (ja) 2014-02-06
CN103833867A (zh) 2014-06-04
JP2009540106A (ja) 2009-11-19
BRPI0713734A2 (pt) 2012-11-06
US9610303B2 (en) 2017-04-04
RU2009101051A (ru) 2010-07-20
CA2655414C (en) 2019-04-23
WO2007146440A2 (en) 2007-12-21
JP2016053080A (ja) 2016-04-14
WO2007146416B1 (en) 2008-04-24
IL195937A0 (en) 2009-09-01
IL195937A (en) 2016-04-21
MX2008016039A (es) 2009-07-10
EP2032180B1 (en) 2017-03-15
US20080108114A1 (en) 2008-05-08
CN101553261B (zh) 2014-01-29
RU2490279C2 (ru) 2013-08-20
US20170304352A1 (en) 2017-10-26
US20080103112A1 (en) 2008-05-01

Similar Documents

Publication Publication Date Title
HK1138215A1 (en) Glucan preparations
HK1140388A1 (en) Mechanic-magnetic connecting structure
IL180020A0 (en) Encryption -and decryption-enabled interfaces
GB0623395D0 (en) Port
EP2023449A4 (en) CONNECTOR
EP1984004A4 (en) THE THERAPY REINFORCING GLUCAN
GB0608444D0 (en) Dialysis
EP2065801A4 (en) EMULATOR
EP2192338B8 (de) Anschlussstück
HK1135606A1 (en) Powdery cosmetic
HK1135617A1 (en) Shampoo composition
AP2008004724A0 (en) Substituted1-yl)-azolin-2-aryl-1-hetaryl-ethane
GB0622181D0 (en) Arginase
GB0718346D0 (en) Tooth-bleaching preparations
GB2445031B (en) Pilaster
GB0607223D0 (en) Abutment member
GB0713585D0 (en) Equivalent
GB0617223D0 (en) Complex
GB2429022B (en) Abutment member
TWI319058B (en) Connecting member
AU4914P (en) CalflatGL Calothamnus quadrifidus
AU3514P (en) ARCBENT Arctotis fastuosa
HU0600039V0 (en) Cosmetic preparation
AU2006907059A0 (en) Why we do what we do
GB0622609D0 (en) Concept 36A